The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, is showcasing Indian pharmaceutical and MedTech innovations at the 45th India International Trade Fair (IITF) 2026 organized by India Trade Promotion Organisation at Bharat Mandapam, New Delhi. The Department has sponsored stalls in the 'Hall of Inspiration' in collaboration with the Department for Promotion of Industry and Internal Trade from November 19th to 23rd, 2026, providing a platform for promising startups to showcase their products, prototypes, technologies and innovative solutions.
Shri Awadhesh Kumar Choudhary, Senior Economic Advisor, Department of Pharmaceuticals, inaugurated the Department's stalls on November 19th in the presence of senior officers and officials. The exhibition features innovations from 10 startups supported under the Promotion of Research and Innovation in Pharma-MedTech (PRIP) scheme, highlighting India's growing capabilities in healthcare research, product development and indigenous technology.
The showcased innovations include AI-powered microscopes and automated diagnostic machines for disease detection including tuberculosis through genetic testing, affordable AI-enabled bionic ear implants and rehabilitation devices for people with hearing impairment, and protective surgical helmets designed for doctors performing complex procedures such as hip and knee replacements. The exhibition also features advanced vaccine and biological medicine development technologies including 3D tumour models to help assess chemotherapy effectiveness, implantable bone-lengthening devices for limb reconstruction, CAR-T cell therapies for blood cancers, and gene therapies for inherited blood disorders.
Additional innovations presented include AI-designed oral medicines under development for obesity and diabetes, regenerative medicine technologies for repairing damaged tissues and treating eye, liver and lung conditions, portable blood-testing machines capable of delivering blood count results in just 10 minutes, and affordable, indigenous molecular diagnostic kits and machines for detecting infections such as tuberculosis and COVID-19. This initiative reflects the Department's commitment to promoting indigenous innovation, strengthening Indian pharmaceutical and MedTech startups, and supporting the development of a robust, competitive innovation-driven ecosystem in the country.